Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort.
Poston JN, Bryan C, von Drygalski A, Al Banaa K, Zhou JY, Parnes A, Chen EC, Khan O, Ellsworth P, Cafuir L, Walsh C, Escobar MA, Wu JF, Malec LM, Kessler CM, Janbain M, Kruse-Jarres R. Poston JN, et al. Among authors: janbain m. Blood Adv. 2024 Nov 26;8(22):5896-5905. doi: 10.1182/bloodadvances.2024013882. Blood Adv. 2024. PMID: 39361769 Free PMC article.
Acquired hemophilia A: emerging treatment options.
Janbain M, Leissinger CA, Kruse-Jarres R. Janbain M, et al. J Blood Med. 2015 May 8;6:143-50. doi: 10.2147/JBM.S77332. eCollection 2015. J Blood Med. 2015. PMID: 26056504 Free PMC article. Review.
Protein S antibody as an adjunct therapy for hemophilia B.
Wilson HP, Pierre A, Paysse AL, Kumar N, Cooley BC, Rudra P, Dorsey AW, Polania-Villanueva D, Chatterjee S, Janbain M, Velez MC, Majumder R. Wilson HP, et al. Among authors: janbain m. Blood Adv. 2024 Jan 23;8(2):441-452. doi: 10.1182/bloodadvances.2023010819. Blood Adv. 2024. PMID: 37773781 Free PMC article.
18 results